跳至主要内容
临床试验/CTRI/2024/12/077606
CTRI/2024/12/077606尚未招募4 期

A clinical prospective double blinded randomized controlled study to compare the intrathecal ropivacaine and dexmedetomidine with intrathecal ropivacaine in infraumblical surgeries.

pacific medical college and hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年12月16日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
-Duration of analgesia

研究概览

简要总结

To assess safety and efficacy of intrathecal Heavy inj.Ropivacaine (3ml) plus

Dexmedetomidine (7mcg) versus a combination of intrathecal Heavy inj.Ropivacaine

(3ml) and normal saline

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Age group 18–60 years of either sex.
  • ASA physical status 1 and
  • Patients posted for Infraumbilical surgeries.

排除标准

  • The following criteria were excluded from the study:
  • Patient refusal.
  • Patients with contraindication to spinal anaesthesia.
  • Patients with any systemic disease.
  • Allergy to either drug used in the study.
  • History of substance abuse.

结局指标

主要结局

-Duration of analgesia

时间窗: 24 MONTHS

-Post operative analgesic requirement

时间窗: 24 MONTHS

-Side effects if any

时间窗: 24 MONTHS

-VAS score

时间窗: 24 MONTHS

次要结局

  • Duration of analgesia(Side effects if any)

研究者

发起方
pacific medical college and hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Robin Arora

Pacific Medical College and Hospital Udaipur

研究点 (1)

Loading locations...

相似试验